Meunier Carlin & Curfman

Firm overview:

Atlanta firm Meunier Carlin & Curfman, one of the largest IP boutiques in the Southeast, protects technology and innovation across industries, including software, electrical, biotech, chemical, artificial intelligence and machine learning. The firm supports clients in preparing patent applications, filing applications in the US and abroad, monitoring competitor applications and technologies, and handling administrative appeals and petitions.

MCC’s Patent Litigation team represents clients in the federal court system, and has helped clients to achieve victory on motions to dismiss, summary judgments, preliminary and permanent injunctions, trials, and appeals. The team has experience with bench and jury trials in the major patent districts across the country, as well as Federal Courts of Appeals.

The team is active in post-grant proceedings before the Patent Trial and Appeal Board (PTAB), having handled almost 40 patent challenges cases.

MCC supports its clients’ global corporate strategy via a network of foreign associates to manage patent prosecution and secure international collateral patent rights.

Team overview:

The firm’s patent attorneys and agents hold advanced technical degrees and have worked as university scientists and researchers, as in-house counsel in the intellectual property departments of major companies, as examiners at the United States Patent and Trademark Office (USPTO), and as corporate scientists and engineers.

Christopher Curfman counsels clients ranging from universities to small corporations on chemical, pharmaceutical and biotechnology-related technologies on patent prosecution with a focus on the life sciences industry. Curfman is the contact for the firm’s international referral relationship firms. He has degrees in biology and chemistry and a PhD in organic chemistry.